Caduet

GPTKB entity

Statements (56)
Predicate Object
gptkbp:instanceOf pharmaceutical drug
gptkbp:activeDuring Amlodipine besylate
Atorvastatin calcium
gptkbp:approves gptkb:FDA
gptkbp:clinicalTrials Caduet_efficacy_study
Caduet_safety_study
Caduet_vs._placebo
gptkbp:contains Atorvastatin
Amlodipine
gptkbp:contraindication muscle pain
swelling
chest pain
liver disease
pregnancy
rash
shortness of breath
allergy to components
gptkbp:dosageForm once daily
gptkbp:drugInterdiction true
oral bioavailability
calcium channel blocker
HMG-CoA reductase inhibitor
hepatic metabolism
renal excretion
gptkbp:formFactor tablet
gptkbp:hasPopulation adults
elderly
patients with cardiovascular disease
patients with diabetes
https://www.w3.org/2000/01/rdf-schema#label Caduet
gptkbp:interactsWith certain antibiotics
antifungal medications
grapefruit juice
gptkbp:label patient information leaflet
medication guide
black box warning
prescribing information
gptkbp:marketedAs gptkb:Australia
gptkb:Canada
gptkb:European_Union
gptkb:Japan
gptkb:United_States
2003
gptkbp:packaging blister pack
gptkbp:patentExpiration 2021
gptkbp:producedBy gptkb:Pfizer
gptkbp:route oral
gptkbp:sideEffect dizziness
fatigue
headache
nausea
abdominal pain
gptkbp:storage room temperature
gptkbp:type false
gptkbp:usedFor hypertension
high cholesterol